Developer of a cerebrovascular thrombus removal device designed to treat acute cerebral infarction. The company's device supports a wide range of blood vessels, improves visibility by placing a visibility marker in the center, and offers low friction coefficient, enabling healthcare providers to improve the lives of the patients and cure them.
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
2. Merger/Acquisition | 14-Feb-2017 | 00.000 | Completed | Generating Revenue | ||
1. Early Stage VC (Series A) | 12-Sep-2014 | 00.000 | 00.000 | Completed | Generating Revenue |
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20210145617-A1 | Stent and method for inspection thereof | Pending | 15-Nov-2019 | 00000000 | |
JP-2021078619-A | Stent and inspection method thereof | Pending | 15-Nov-2019 | 00000000 | 0 |
EP-3821857-A1 | Stent and method for inspection thereof | Pending | 15-Nov-2019 | 00000000 | 0 |
JP-2015008931-A | Highly-flexible stent | Granted | 28-Jun-2013 | 00000000 | 0 |
JP-5586742-B1 | High flexibility stent | Active | 28-Jun-2013 | A61F2/88 | 00 |
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Kazuya Shobayashi | Chief Executive Officer |